Latest stories on NVCT
Nuvectis Pharma’s NXP900 Combo Trial Adds Fresh Momentum to NVCT in EGFR Lung Cancer
TipRanks73 · bullishproduct/pr
Nuvectis: 'Hold' On NXP800 Removal And Newly Licensed Candidates
Seeking Alpha42 · neutralanalyst
Nuvectis Pharma, Inc. (NVCT) files 8-K
SEC 8-K50 · neutralgeneral
Nuvectis Pharma shares slide after pricing $100 million discounted stock offering (NVCT)
Yahoo Finance24 · bearishgeneral
At a glance: stocks gapping down premarket
Seeking Alpha32 · bearishgeneral
Nuvectis Pharma Raises $100 Million to Accelerate Pipeline—NXP100, NXP900, and NXP200 in Focus
MarketChameleon24 · bearishgeneral
Biggest stock movers Tuesday: ABVX, AVAV, and more
Seeking Alpha50 · neutralgeneral
Nuvectis Pharma shares slide 19% on pricing of $100M stock offering
Seeking Alpha24 · bearishgeneral
Nuvectis Pharma Announces Pricing of $100 Million Public Offering of Common Stock | NVCT Stock News
StockTitan24 · bearishgeneral
Nuvectis Pharma Suspends Equity Offering Program Under Agreement
TipRanks28 · bearishgeneral
Nuvectis Pharma announces public share offering to support drug programs
Seeking Alpha28 · bearishgeneral
Nuvectis Pharma, Inc. (NVCT) files 8-K
SEC 8-K50 · neutralgeneral
Nuvectis Pharma Announces Proposed Public Offering of Common Stock | NVCT Stock News
StockTitan24 · bearishgeneral
Haisco and Nuvectis sign licensing deal for two drugs
Yahoo Finance56 · neutralgeneral
Nuvectis Pharma Expands Portfolio with Haisco License Deal
TipRanks56 · neutralgeneral
Nuvectis Pharma, Inc. (NVCT) files 8-K
SEC 8-K50 · neutralgeneral
Nuvectis Pharma, Inc. (NVCT) files 8-K
SEC 8-K50 · neutralgeneral